Altium Capital Management LP - Q2 2019 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q2 2019
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FAT BRANDS INC12Q3 20230.6%
CHINOOK THERAPEUTICS INC11Q2 20238.9%
BELLUS HEALTH INC NEW10Q1 20234.7%
XTANT MED HLDGS INC10Q3 20235.1%
IVERIC BIO INC10Q1 20232.3%
MYRIAD GENETICS INC10Q1 20232.3%
HARBOR CUSTOM DEVELOPMENT IN10Q3 20230.1%
CRINETICS PHARMACEUTICALS IN9Q3 20234.1%
CTI BIOPHARMA CORP9Q1 20232.6%
POLISHED COM INC9Q2 20233.4%

View Altium Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Altium Capital Management LP Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Marpai, Inc.April 26, 20231,805,3276.2%
Astria Therapeutics, Inc.February 14, 20231,355,3725.0%
HyreCar Inc.February 14, 20231,688,1205.6%
Muscle Maker, Inc.February 14, 20232,888,0855.0%
NeuroBo Pharmaceuticals, Inc.Sold outFebruary 14, 202300.0%
PALISADE BIO, INC.Sold outFebruary 14, 202300.0%
1847 Goedeker Inc.February 14, 20226,103,8245.0%
BioRestorative Therapies, Inc.February 14, 2022200,0005.0%
BriaCell Therapeutics Corp.February 14, 2022900,0004.7%
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.February 14, 2022363,0005.0%

View Altium Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-02-21
SC 13G2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View Altium Capital Management LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Altium Capital Management LP's holdings

CSVXLS